AlphaStar Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.19M | Sell |
19,244
-6,013
| -24% | -$1.33M | 0.31% | 52 |
|
|
2025
Q4 | $5.77M | Buy |
25,257
+1,033
| +4% | +$235K | 0.42% | 38 |
|
|
2025
Q3 | $5.61M | Buy |
24,224
+1,182
| +5% | +$241K | 0.48% | 33 |
|
|
2025
Q2 | $4.28M | Sell |
23,042
-1,412
| -6% | -$262K | 0.3% | 61 |
|
|
2025
Q1 | $5.12M | Sell |
24,454
-8,579
| -26% | -$1.67M | 0.52% | 32 |
|
|
2024
Q4 | $5.87M | Buy |
33,033
+3,607
| +12% | +$663K | 0.61% | 25 |
|
|
2024
Q3 | $5.81M | Buy |
29,426
+1,849
| +7% | +$345K | 0.46% | 34 |
|
|
2024
Q2 | $4.73M | Buy |
27,577
+1,242
| +5% | +$206K | 0.44% | 31 |
|
|
2024
Q1 | $4.8M | Buy |
26,335
+2,339
| +10% | +$403K | 0.49% | 30 |
|
|
2023
Q4 | $3.72M | Buy |
23,996
+581
| +2% | +$84.7K | 0.34% | 41 |
|
|
2023
Q3 | $3.49M | Sell |
23,415
-483
| -2% | -$70.9K | 0.44% | 29 |
|
|
2023
Q2 | $3.22M | Buy |
23,898
+73
| +0.3% | +$10.7K | 0.36% | 37 |
|
|
2023
Q1 | $3.8M | Sell |
23,825
-7,894
| -25% | -$1.21M | 0.32% | 48 |
|
|
2022
Q4 | $5.13M | Buy |
31,719
+8,224
| +35% | +$1.26M | 0.53% | 37 |
|
|
2022
Q3 | $3.15M | Buy |
23,495
+1,226
| +6% | +$176K | 0.34% | 52 |
|
|
2022
Q2 | $3.41M | Buy |
22,269
+1,415
| +7% | +$216K | 0.32% | 57 |
|
|
2022
Q1 | $3.38M | Buy |
20,854
+619
| +3% | +$89.9K | 0.27% | 69 |
|
|
2021
Q4 | $2.75M | Sell |
20,235
-4,106
| -17% | -$485K | 0.22% | 95 |
|
|
2021
Q3 | $2.64M | Buy |
24,341
+9,783
| +67% | +$1.12M | 0.18% | 102 |
|
|
2021
Q2 | $1.64M | Buy |
14,558
+1,532
| +12% | +$173K | 0.21% | 92 |
|
|
2021
Q1 | $1.41M | Sell |
13,026
-82
| -0.6% | -$8.77K | 0.22% | 85 |
|
|
2020
Q4 | $1.47M | Buy |
13,108
+5,422
| +71% | +$521K | 0.25% | 80 |
|
|
2020
Q3 | $657K | Buy |
7,686
+2,416
| +46% | +$227K | 0.13% | 106 |
|
|
2020
Q2 | $530K | Buy |
5,270
+536
| +11% | +$47.2K | 0.11% | 109 |
|
|
2020
Q1 | $380K | Sell |
4,734
-25
| -0.5% | -$2.13K | 0.09% | 129 |
|
|
2019
Q4 | $421K | Buy |
4,759
+513
| +12% | +$42.6K | 0.09% | 140 |
|
|
2019
Q3 | $322K | Sell |
4,246
-306
| -7% | -$21K | 0.08% | 156 |
|
|
2019
Q2 | $331K | Sell |
4,552
-93
| -2% | -$7.31K | 0.08% | 160 |
|
|
2019
Q1 | $374K | Buy |
4,645
+207
| +5% | +$16.9K | 0.1% | 140 |
|
|
2018
Q4 | $409K | Sell |
4,438
-25
| -0.6% | -$2.2K | 0.13% | 125 |
|
|
2018
Q3 | $422K | Sell |
4,463
-193
| -4% | -$18.3K | 0.12% | 142 |
|
|
2018
Q2 | $431K | Sell |
4,656
-456
| -9% | -$44.5K | 0.14% | 142 |
|
|
2018
Q1 | $484K | Buy |
5,112
+261
| +5% | +$28.7K | 0.18% | 103 |
|
|
2017
Q4 | $469K | Buy |
+4,851
| New | +$457K | 0.12% | 107 |
|
Other funds holding ABBV
VCM
VPM
AlphaStar Capital Management's ABBV Position: Q1 2026 in Review
AlphaStar Capital Management reduced its AbbVie (ABBV) stake by 24% in Q1 2026, selling an estimated $1.33M and leaving 19,244 shares worth $4.19M. The position accounts for 0.31% of the portfolio, ranked #52.
AlphaStar Capital Management first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.87M in Q4 2024. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- AlphaStar Capital Management held 19,244 shares of AbbVie worth $4.19M as of Q1 2026.
- AlphaStar Capital Management sold 6,013 AbbVie shares in Q1 2026, an estimated $1.33M.
- AbbVie made up 0.31% of AlphaStar Capital Management's portfolio in Q1 2026, its #52 holding.
- AlphaStar Capital Management first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- AlphaStar Capital Management's AbbVie position peaked at $5.87M in Q4 2024.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on AlphaStar Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.